Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium

Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium. Hässler, Signe; Bachelet, Delphine; Duhaze, Julianne; Szely, Natacha; Gleizes, Aude; Hacein-Bey Abina, Salima; Aktas, Orhan; Auer, Michael; Avouac, Jerôme; Birchler, Mary; Bouhnik, Yoram; Brocq, Olivier; Buck-Martin, Dorothea; Cadiot, Guillaume; Carbonnel, Franck; Chowers, Yehuda; Comabella, Manuel; Derfuss, Tobias; De Vries, Niek; Donnellan, Naoimh; Doukani, Abiba; Guger, Michael; Hartung, Hans-Peter; Kubala Havrdova, Eva; Hemmer, Bernhard; Huizinga, Tom; Ingenhoven, Kathleen; Hyldgaard-Jensen, Poul Erik; Jury, Elizabeth C.; Khalil, Michael; Kieseier, Bernd; Laurén, Anna; Lindberg, Raija; Loercher, Amy; Maggi, Enrico; Manson, Jessica; Mauri, Claudia; Mohand Oumoussa, Badreddine; Montalban, Xavier; Nachury, Maria; Nytrova, Petra; Richez, Christophe; Ryner, Malin; Sellebjerg, Finn; Sievers, Claudia; Sikkema, Dan; Soubrier, Martin; Tourdot, Sophie; Trang, Caroline; Vultaggio, Alessandra; Warnke, Clemens; Spindeldreher, Sebastian; Dönnes, Pierre; Hickling, Timothy P.; Hincelin Mery, A. PLoS medicine. 2020; 17: p.e1003348. doi:10.1371/journal.pmed.1003348
Article